Re-evaluation of locust bean gum (E 410) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as a food additive for uses in foods for all population groups.
E 410
food additive
infants
locust bean gum
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
entrez:
15
2
2023
pubmed:
16
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Locust bean gum (E 410) was re-evaluated in 2017 by the former EFSA Panel on Food Additives and Nutrient sources added to Food (ANS). As a follow-up to that assessment, the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of locust bean gum (E 410) for its uses as a food additive in food for infants below 16 weeks of age belonging to food category 13.1.5.1 (Dietary foods for infants for special medical purposes and special formulae for infants). In addition, the FAF Panel was requested to address the issues already identified during the re-evaluation of the food additive when used in food for the general population, including the safety assessment for FC 13.1.5.1 and 13.1.5.2 (Dietary foods for babies and young children for special medical purposes as defined in directive 1999/21/EC). The process involved the publication of a call for data. Based on the received data, the Panel concluded that the technical data provided by the interested business operators support an amendment of the specifications for locust bean gum (E 410) laid down in Commission Regulation (EU) No 231/2012. The Panel identified a reference point of 1,400 mg/kg bw per day based on reduced blood zinc levels in a piglet study. It applied the margin of exposure (MoE) for the safety assessment of locust bean gum (E 410) when used as a food additive in FC 13.1.5.1 and 13.1.5.2. The Panel concluded that a MoE above 1 would not raise a safety concern. A MoE above 1 was obtained for some of the scenarios and exposure levels for infants. For toddlers (consumers only of food for special medical purposes), the MoE was above 1 for all exposure levels.
Identifiants
pubmed: 36789355
doi: 10.2903/j.efsa.2023.7775
pii: EFS27775
pmc: PMC9909383
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e07775Informations de copyright
© 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.
Références
Front Immunol. 2020 Jun 03;11:943
pubmed: 32582146
Food Chem. 2014 Sep 15;159:5-11
pubmed: 24767020
Pediatr Gastroenterol Hepatol Nutr. 2020 Nov;23(6):511-520
pubmed: 33215022
Molecules. 2009 Jul 16;14(7):2602-20
pubmed: 19633627
Clin Nephrol. 2008 Jul;70(1):1-9
pubmed: 18793542
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):649-667
pubmed: 33948025
Biol Trace Elem Res. 2001 Jul;81(1):79-92
pubmed: 11508334
J Pediatr Gastroenterol Nutr. 1999 Oct;29(4):475-6
pubmed: 10512412
Chem Biodivers. 2005 Mar;2(3):295-317
pubmed: 17191982
Front Nutr. 2022 Mar 09;9:717064
pubmed: 35356730
EFSA J. 2017 May 31;15(5):e04849
pubmed: 32625502
World Health Organ Tech Rep Ser. 1980;653:1-38
pubmed: 6784351
Am J Clin Nutr. 2010 Apr;91(4):1027-34
pubmed: 20147474
EFSA J. 2022 Oct 25;20(10):e07584
pubmed: 36304832
J Investig Allergol Clin Immunol. 2020;30(3):197-199
pubmed: 32043466
EFSA J. 2023 Feb 09;21(2):e07775
pubmed: 36789355
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421
EFSA J. 2021 Aug 03;19(8):e06769
pubmed: 34377191